GS-03-Global Real World Evidence of Sofosbuvir/Velpatasvir as a Simple, Effective Regimen for the Treatment of Chronic Hepatitis C Patients: Integrated Analysis of 12 Clinical Practice Cohorts - Sorbonne Université Access content directly
Journal Articles Journal of Hepatology Year : 2019

GS-03-Global Real World Evidence of Sofosbuvir/Velpatasvir as a Simple, Effective Regimen for the Treatment of Chronic Hepatitis C Patients: Integrated Analysis of 12 Clinical Practice Cohorts

Domains

Life Sciences [q-bio]

Gestionnaire HAL 4 Sorbonne Université  : Connect in order to contact the contributor

https://hal.sorbonne-universite.fr/hal-03777528

Submitted on : Wednesday, September 14, 2022-5:40:39 PM

Last modification on : Saturday, October 7, 2023-9:36:26 PM

No file

Dates and versions

hal-03777528 , version 1 (14-09-2022)

Identifiers

Cite

Alessandra Mangia, Scott Milligan, Mandana Khalili, Stefano Fagiuoli, Stephen Shafran, et al.. GS-03-Global Real World Evidence of Sofosbuvir/Velpatasvir as a Simple, Effective Regimen for the Treatment of Chronic Hepatitis C Patients: Integrated Analysis of 12 Clinical Practice Cohorts. Journal of Hepatology, 2019, 70 (1), pp.e2-e3. ⟨10.1016/S0618-8278(19)30003-9⟩. ⟨hal-03777528⟩

Export

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

UBS IRISA_UBS IPLESP SORBONNE-UNIVERSITE SU-MEDECINE
32 View
0 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More